Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma

BACKGROUND: High tumor mutation burden (TMB) has gradually become a sensitive biomarker for predicting the response to immunotherapy in many cancers, including lung, bladder and head and neck cancers. However, whether high TMB predicts the response to immunotherapy and prognosis in pancreatic ductal...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Cell Int
Главные авторы: Tang, Rong, Liu, Xiaomeng, Wang, Wei, Hua, Jie, Xu, Jin, Liang, Chen, Meng, Qingcai, Liu, Jiang, Zhang, Bo, Yu, Xianjun, Shi, Si
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Primary Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8028808/
https://ncbi.nlm.nih.gov/pubmed/33827590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-021-01900-4
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы